Oncolytics Biotech ONCY
NASDAQ ONCY
$0.41 +0.03 (+7.81%)
At close: Nov 11, 2026 · 4:00 PM EST

Oncolytics Biotech (ONCY) Depreciation and Depletion (2025 - 2026)

Updated

Oncolytics Biotech (ONCY) reported Depreciation and Depletion of $70,000 for FY2025, down 19.5% from $87,000 in FY2024.

Analysis

Oncolytics Biotech (ONCY) Depreciation and Depletion (2025 - 2026) Analysis & Trends

Dating back to FY2016, Oncolytics Biotech's Depreciation and Depletion record includes 10 years.

  • Depreciation and Depletion has a five-year compound annual growth rate of 1.1% (FY2020 to FY2025).
  • Five-year annual Depreciation and Depletion spans a low of $60,034 in FY2023 and a high of $103,734 in FY2021.
  • According to Business Quant data, Depreciation and Depletion came in at $87,000 in FY2024 (+44.9%), $60,034 in FY2023 (-16.1%), $71,532 in FY2022 (-31.0%) and $103,734 in FY2021 (+56.1%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Oncolytics Biotech 47.36 Mn 23.68 Mn - 15,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15,000.00
Mar 31, 2026 16,000.00
Jun 30, 2025 18,000.00
Mar 31, 2025 19,000.00
API Access

Oncolytics Biotech Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ONCY&period=max&api_key=YOUR_API_KEY